ZEDOCEF CV 50 ORAL SUSPENSION is a combination of Cefpodoxime and Clavulanic acid which belongs to the group of medicines called Cephalosporins and Beta-lactamase inhibitors, respectively. ZEDOCEF CV 50 ORAL SUSPENSION is used in children to manage mild to moderate infections such as otitis media (middle ear infection), nose & throat infections, respiratory tract infection, urinary tract infection, reproductive tract infection, and skin infection.
ZEDOCEF CV 50 ORAL SUSPENSION is not recommended for use in children allergic to Cefpodoxime, Clavulanic acid, and/or other cephalosporin group of antibiotics. It is also not recommended for use in children suffering from galactose intolerance, Lapp lactase deficiency (lactose intolerance), and glucose-galactose malabsorption (condition marked by body’s inability to absorb glucose and galactose sugars).
Before administering ZEDOCEF CV 50 ORAL SUSPENSION, inform your doctor if the child has previous history of hypersensitivity reactions to medicines such as cefpodoxime, other cephalosporins, penicillin, and/or have kidney problems (such as mild/moderate/severe renal impairment), and liver problems (such as hepatic insufficiency/impairment).
ZEDOCEF CV 50 ORAL SUSPENSION is not recommended for use in pregnant and breastfeeding women since it is used only in children
(aged below 12 years). It is also not recommended for use in elderly patients.
The most common side effects of administering ZEDOCEF CV 50 ORAL SUSPENSION in child are diarrhoea, nausea, vomiting, abdominal pain, headache, vaginal fungal infections, and/or vulvovaginal infections. Consult your doctor if any of these symptoms worsens.
No content available
